S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges

By Lenz Johannes Carl Christoph   Rockstroh Jüürgen Kurt  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 537-548

Informa Healthcare

Access to resources Recommend Favorite

Editorial: HIV and Antiretroviral Drugs: Current Status and New Challenges

By  

Current Pharmaceutical Design, Vol. 23, Iss. 18, 2017-07 ,pp. : 2551-2551

Bentham Science Publishers

Access to resources Recommend Favorite

The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 76-110

Bentham Science Publishers

Access to resources Recommend Favorite

New insights into asthma pathogenesis

By  

Inpharma, Vol. 1, Iss. 1347, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Vicriviroc, a new CC-chemokine receptor 5 inhibitor for treatment of HIV: properties, promises and challenges

By Lenz Johannes Carl Christoph   Rockstroh Jürgen Kurt  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1139-1150

Informa Healthcare

Access to resources Recommend Favorite